Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
Delayed Nasdaq  -  04:00 2022-09-28 pm EDT
40.23 USD   +4.33%
09/19Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone
BU
09/12Transcript : Sage Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 03:40 PM
CI
09/05Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on SAGE THERAPEUTICS, INC.
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Ra..
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Ratin..
MT
07/11SVB Securities Adjusts Sage Therapeutics' Price Target to $40 from $50, Keeps Market Pe..
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcar..
MT
06/02RBC Capital Adjusts Price Target for Sage Therapeutics to $37 From $35, Maintains Secto..
MT
05/24Goldman Sachs Lowers Sage Therapeutics' Price Target to $73 From $85, Maintains Buy Rat..
MT
05/10Morgan Stanley Adjusts Sage Therapeutics' Price Target to $53 from $57, Keeps Equalweig..
MT
05/04Mizuho Securities Adjusts Sage Therapeutics' Price Target to $37 From $41, Maintains Ne..
MT
05/04RBC Cuts Price Target on Sage Therapeutics to $35 From $37, Citing Cash Burn Guidance, ..
MT
05/03Wedbush Lowers Price Target for Sage Therapeutics to $54 From $75, Maintains Outperform..
MT
03/31Berenberg Bank Initiates Sage Therapeutics at Hold With $37 Price Target
MT
03/10Morgan Stanley Adjusts Sage Therapeutics' Price Target to $57 from $61, Keeps Equalweig..
MT
03/03Mizuho Securities Adjusts Sage Therapeutics' Price Target to $41 From $44, Maintains Ne..
MT
02/25Stifel Nicolaus Lower Price Target for Sage Therapeutics to $58 From $75, Maintains Buy..
MT
02/25Goldman Sachs Lowers Sage Therapeutics' Price Target to $85 From $96, Maintains Buy Rat..
MT
02/25Canaccord Genuity Lowers Price Target for Sage Therapeutics to $64 From $96, Maintains ..
MT
02/25SVB Leerink Lowers Sage Therapeutics Price Target to $50 From $60, Maintains Market Per..
MT
02/25Wedbush Cuts Price Target on Sage Therapeutics to $75 From $79, Citing Lower Zulresso E..
MT
02/17Oppenheimer Adjusts Sage Therapeutics' Price Target to $74 From $80, Maintains Outperfo..
MT
02/17RBC Cuts Price Target on Sage Therapeutics to $42 From $48, Maintains Sector Perform-Sp..
MT
02/17Goldman Sachs Adjusts Sage Therapeutics' Price Target to $96 From $174, Reiterates Buy ..
MT
01/06Needham Adjusts Sage Therapeutics Price Target to $85 From $79, Reiterates Buy Rating
MT
2021SVB Leerink Adjusts Sage Therapeutics PT to $60 From $70, Maintains Market Perform Rati..
MT
2021Mizuho Securities Adjusts Price Target on Sage Therapeutics to $44 From $52, Maintains ..
MT
2021Oppenheimer Cuts PT on Sage Therapeutics to $80 from $84; Outperform Rating Maintained
MT
2021RBC Cuts Price Target on Sage Therapeutics to $48 From $52, Maintains Sector Perform, S..
MT
2021HC Wainwright Adjusts Sage Therapeutics' Price Target to $55 From $80, Maintains Neutra..
MT
2021Wedbush Trims Sage Therapeutics' Price Target to $79 From $80, Keeps Outperform Rating
MT
2021Guggenheim Upgrades Sage Therapeutics to Buy From Neutral, $55 Price Target
MT
2021Sage Therapeutics : Needham Adjusts Price Target on Sage Therapeutics ..
MT
2021Sage Therapeutics : Morgan Stanley Adjusts Sage Therapeutics' Price Ta..
MT
2021Sage Therapeutics : Morgan Stanley Adjusts Price Target on Sage Therap..
MT
2021Sage Therapeutics : Jefferies Assumes Sage Therapeutics at Hold, Sets ..
MT
2021Sage Therapeutics : Stifel Adjusts Sage Therapeutics PT to $75 from $9..
MT
2021Sage Therapeutics : Needham Starts Sage Therapeutics at Buy With $84 P..
MT
2021Sage Therapeutics : RBC Cuts Price Target on Sage Therapeutics to $55 ..
MT
2021Sage Therapeutics : HC Wainwright Adjusts Sage Therapeutics' Price Tar..
MT
2021Sage Therapeutics : Wedbush Adjusts Price Target for Sage Therapeutics..
MT
2021Sage Therapeutics : Canaccord Genuity Adjusts Price Target on Sage The..
MT
2021Sage Therapeutics' : Price Target From RBC Cut to $60 From $84; Surve..
MT
2021Biogen : Price Target From RBC Cut to $354 From $400 Amid Adjusted Estimates for ..
MT
2021Sage Therapeutics : Mizuho Securities Adjusts Sage Therapeutics' Price..
MT
2021Sage Therapeutics : Cowen Adjusts Sage Therapeutics' Price Target to $..
MT
2021Sage Therapeutics : Guggenheim Downgrades Sage Therapeutics to Neutral..
MT
2021Sage Therapeutics : SVB Leerink Adjusts Sage Therapeutics' Price Targe..
MT
2021Sage Therapeutics : Truist Securities Adjusts Sage Therapeutics' Price..
MT
2021Sage Therapeutics : BMO Capital Adjusts Price Target on Sage Therapeut..
MT
2021Sage Therapeutics : Stifel Adjusts Price Target on Sage Therapeutics t..
MT
2021Sage Therapeutics : William Blair Downgrades Sage Therapeutics to Mark..
MT
2021Sage Therapeutics : Citigroup Downgrades Sage Therapeutics to Neutral ..
MT
2021Sage Therapeutics : Oppenheimer Adjusts Sage Therapeutics PT to $100 F..
MT
2021Sage Therapeutics : RBC Capital Adjusts Sage Therapeutics' Price Targe..
MT
2021Sage Therapeutics : Wedbush Adjusts Price Target on Sage Therapeutics ..
MT
2021Sage Therapeutics : Piper Sandler Starts Sage Therapeutics at Overweig..
MT
2021Sage Therapeutics : Morgan Stanley Adjusts Sage Therapeutics PT to $87..
MT
2021Sage Therapeutics : Mizuho Downgrades Sage Therapeutics to Neutral fro..
MT
2021Sage Therapeutics : Oppenheimer Adjusts Sage Therapeutics PT to $102 F..
MT
2021Sage Therapeutics : RBC Adjusts Sage Therapeutics' Price Target to $89..
MT
2021Sage Therapeutics : Raymond James Reinstates Sage Therapeutics at Mark..
MT
2021Sage Therapeutics : BMO Capital Downgrades Sage Therapeutics to Market..
MT
2021Sage Therapeutics : Wedbush Adjusts Price Target on Sage Therapeutics ..
MT
2021Sage Therapeutics : Guggenheim Upgrades Sage Therapeutics to Buy From ..
MT
2021Sage Therapeutics : RBC Downgrades Sage Therapeutics to Sector Perform..
MT
2020Sage Therapeutics : Mizuho Upgrades Sage Therapeutics to Buy From Neut..
MT
2020Sage Therapeutics : Oppenheimer Adjusts Sage Therapeutics' Price Targe..
MT
2020Sage Therapeutics : Truist Adjusts Sage Therapeutics' Price Target to ..
MT
2020Sage Therapeutics : Morgan Stanley Adjusts Sage Therapeutics' Price Ta..
MT
2020Sage Therapeutics : RBC Capital Adjusts Sage Therapeutics' Price Targe..
MT
2020Sage Therapeutics : HC Wainwright Adjusts Sage Therapeutics' Price Tar..
MT
2020Sage Therapeutics : Raymond James Downgrades Sage Therapeutics to Mark..
MT
2020Sage Therapeutics : Oppenheimer Adjusts Sage Therapeutics PT to $94 Fr..
MT
2020Sage Therapeutics : BofA Securities Adjusts Sage Therapeutics PT to $9..
MT
2020Sage Therapeutics : Morgan Stanley Downgrades Sage Therapeutics to Equ..
MT
2020Sage Therapeutics : BMO Capital Adjusts Sage Therapeutics' Price Targe..
MT
1  2Next
Upcoming event on SAGE THERAPEUTICS, INC.